Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

NCT00041210 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

850

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
DRUG: ABVD regimen
DRUG: Stanford V regimen
DRUG: dacarbazine
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: mechlorethamine hydrochloride
DRUG: prednisone
DRUG: vinblastine sulfate
DRUG: vincristine sulfate
RADIATION: radiation therapy

Sponsor

Mount Vernon Cancer Centre at Mount Vernon Hospital